Researchers at IIT Madras have developed an injectable hydrogel that delivers antifibrotic drugs in a sustained manner, potentially replacing prolonged treatments with a single dose. The innovation, derived from silk and seaweed biomaterials, could significantly reduce treatment costs for chronic fibrosis.